Evidence map›Paper›PMID 39383876›Full record

ArticleStructure (London, England : 1993)2024

Structural mechanism of HP1⍺-dependent transcriptional repression and chromatin compaction.

Vladyslava Sokolova, Jacob Miratsky, Vladimir Svetlov, Michael Brenowitz, John Vant, Tyler S Lewis, Kelly Dryden, Gahyun Lee, Shayan Sarkar, Evgeny Nudler and 2 more

Abstract read
In one paragraph

Article in Structure (London, England : 1993), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Vladyslava SokolovaDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Jacob MiratskySchool of Molecular Sciences, Arizona State University, Tempe, AZ, USA.
Vladimir SvetlovDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Michael BrenowitzDepartments of Biochemistry and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.
John VantSchool of Molecular Sciences, Arizona State University, Tempe, AZ, USA.
Tyler S LewisDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Kelly DrydenMolecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA 22903, USA.
Gahyun LeeDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA.
Shayan SarkarDepartment of Pathology, Stony Brook University, Stony Brook, NY 11794, USA.
Evgeny NudlerDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.
Abhishek SingharoySchool of Molecular Sciences, Arizona State University, Tempe, AZ, USA.
Dongyan TanDepartment of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA. Electronic address: dongyan.tan@stonybrook.edu.

Funding

UVA molecular electron microscopy core for the Mid-Atlantic regionU24GM116790 · NIGMS · UNIVERSITY OF VIRGINIA · PI GALKIN, VITOLD, SAMSO, MONTSERRAT · 2017 to 2021
$2.9M
Dynamics and Regulation of Chromatin in DNA MetabolismR35GM133611 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI TAN, DONGYAN · 2019 to 2023
$2.1M
Molecular Electron Microscopy Core Facility ImprovementsG20RR031199 · NCRR · UNIVERSITY OF VIRGINIA · PI SHUPNIK, MARGARET A · 2010 to 2010
$2.0M
300 keV Liquid Helium Robotic MicroscopeS10RR025067 · NCRR · UNIVERSITY OF VIRGINIA · PI EGELMAN, EDWARD H. · 2009 to 2009
$2.0M
A 200KV CRYO-TEM FOR IMAGING BIOLOGICAL STRUCTURESS10OD012272 · OD · STATE UNIVERSITY NEW YORK STONY BROOK · PI NEIMAN, AARON M · 2015 to 2015
$2.0M
NCRR NIH HHS G20 RR031199NCRR NIH HHS S10 RR025067NIGMS NIH HHS R35 GM133611NIGMS NIH HHS U24 GM116790NIH HHS S10 OD012272
6 · The paper itself

Abstract

Heterochromatin protein 1 (HP1) plays a central role in establishing and maintaining constitutive heterochromatin. However, the mechanisms underlying HP1-nucleosome interactions and their contributions to heterochromatin functions remain elusive. Here, we present the cryoelectron microscopy (cryo-EM) structure of an HP1α dimer bound to an H2A.Z-nucleosome, revealing two distinct HP1α-nucleosome interfaces. The primary HP1α binding site is located at the N terminus of histone H3, specifically at the trimethylated lysine 9 (K9me3) region, while a secondary binding site is situated near histone H2B, close to nucleosome superhelical location 4 (SHL4). Our biochemical data further demonstrates that HP1α binding influences the dynamics of DNA on the nucleosome. It promotes DNA unwrapping near the nucleosome entry and exit sites while concurrently restricting DNA accessibility in the vicinity of SHL4. Our study offers a model for HP1α-mediated heterochromatin maintenance and gene silencing. It also sheds light on the H3K9me-independent role of HP1 in responding to DNA damage.

Indexed as

Chromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneCryoelectron MicroscopyHistonesNucleosomesProtein BindingBinding SitesChromatinDNAHeterochromatinHumansModels, MolecularProtein MultimerizationCBX5 protein, humanChromatinChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneDNAHeterochromatinHistonesNucleosomescryo-EMheterochromatinhistone methylationhistone variantHPMDFFnucleosome

Identifiers

PMID39383876
PMCPMC11560701

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.